Surescripts is the dominant US e-prescribing network: nearly all electronic prescriptions in the country traverse it, linking prescriber systems, pharmacies, and payers. Beyond routing prescriptions, it operates services prescribers rely on at the point of care, such as medication history (what a patient has been dispensed elsewhere) and benefit and eligibility information that informs what a plan will cover. In practice it is the connective tissue of US outpatient prescribing.
For a telemedicine product, the key fact is that you do not integrate with Surescripts casually. The certification and security requirements to connect directly are substantial, so most platforms reach the network through an embedded e-prescribing partner — a certified module or API vendor that has already done that work and exposes it to you. This is especially true where controlled substances are involved, because electronic prescribing of controlled substances (EPCS) adds DEA-driven identity-proofing and signing requirements on top.
The engineering and planning implication is to treat this as a dependency to lock in early. Your prescribing features inherit the partner's certification scope, supported transaction types, and release timelines, so the partner choice shapes what you can ship and when. The common mistake is scoping prescribing as if it were just another internal feature and discovering late that the real gate is a third party's certification roadmap — a dependency that can add months if it is not planned from the start.
